Optica releases data on spiral diopter lens developed for multifocal vision correction


The technology has potential for applications in contact lenses and intraocular implants

The new spiral diopter lens could be used on contact lenses (shown here, held in front of an eye), in intraocular implants for cataracts and to create new types of miniaturised imaging systems. Image credit: Laurent Galinier

The new spiral diopter lens could be used on contact lenses (shown), in intraocular implants for cataracts and to create new types of miniaturised imaging systems. Image credit: Laurent Galinier

Research findings published in Optica indicate a new spiral lens could provide similar benefits to progressive lenses, with less visual distortion than those solutions currently on the market. The investigators’ findings, as described by Optica Publishing Group in a news release, demonstrate that the spiral diopter lens creates several separate points of focus within one lens.1 This structure provides the multifocal effect of a progressive lens, but with minimised distortion, the researchers reported. A spiral diopter lens could function in a contact lens or intraocular implant, and also boasts applications in imaging systems.

The data comes out of Photonics, Numerical and Nanosciences Laboratory (LP2N), a joint research unit between the Institut d'Optique Graduate School, the University of Bordeaux and the CNRS in France. Investigator Bertrand Simon, PhD, an associate professor at Institut d’Optique, said the spiral shape has far-reaching implications, particularly for those with age-related farsightedness. “Unlike existing multifocal lenses, our lens performs well under a wide range of light conditions and maintains multifocality regardless of the size of the pupil,” Prof Simon said.

The paper’s first author, Laurent Galinier from SPIRAL SAS in France, explained the lens structure as an “optical vortex,” which causes light to spin. In the news release, he stated the new lens “incorporates the elements necessary to make an optical vortex directly into its surface.”

“Creating optical vortices is a thriving field of research, but our method simplifies the process, marking a significant advancement in the field of optics,” Galinier added.

In Optica, Optica Publishing Group’s journal, the researchers describe the new lens, which they call the spiral diopter. Its spiraling features are arranged in a way that creates many separate points of focus — much like having multiple lenses in one. This makes it possible to see clearly at various distances.

While developing the lens, the authors noted that image quality appears to be maintained at a satisfactory level with modification of aperture size. In addition, the structure of the optical vortex, and its number and position of focus points, could be changed by adjusting the topological charge, or number of spirals around the centre axis.1 Future trials will document the performance of the spiral diopter lens in real-world conditions, including varying light levels. Further research is expected to illuminate potential applications including prescription eyeglasses, compact imaging systems and wearable devices.


  1. Spiral-shaped lens provides clear vision at a range of distances and lighting conditions. News release. Optica Publishing Group. Accessed February 5, 2024.

Recent Videos
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
© 2024 MJH Life Sciences

All rights reserved.